Skip to content
naulon

Corrected on Aug 31, 2022.

Source: the publisher, via Crossref · checked Nov 3, 2026 · Read the notice

Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome

Carter Merenstein, Guanxiang Liang, Samantha A. Whiteside and 18 more

mBio · 2021 · CC BY

doi:10.1101/2021.04.02.21254514

Abstract

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of the respiratory tract, results in highly variable outcomes ranging from minimal illness to death, but the reasons for this are not well understood. We investigated the respiratory tract bacterial microbiome and small commensal DNA viruses in hospitalized COVID-19 patients and found that each was markedly abnormal compared to that in healthy people and differed from that in critically ill patients without COVID-19.

Cited by papers we hold 1

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.